Cargando…

Targeting Lymphoma-associated Macrophage Expansion via CSF1R/JAK Inhibition is a Therapeutic Vulnerability in Peripheral T-cell Lymphomas

The reciprocal relationship between malignant T cells and lymphoma-associated macrophages (LAM) within the tumor microenvironment (TME) is unique, as LAMs are well poised to provide ligands for antigen, costimulatory, and cytokine receptors that promote T-cell lymphoma growth. Conversely, malignant...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Xin, Kady, Nermin, Wang, Chenguang, Abdelrahman, Suhaib, Gann, Peter, Sverdlov, Maria, Wolfe, Ashley, Brown, Noah, Reneau, John, Robida, Aaron M., Murga-Zamalloa, Carlos, Wilcox, Ryan A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Association for Cancer Research 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035520/ https://www.ncbi.nlm.nih.gov/pubmed/36970721 http://dx.doi.org/10.1158/2767-9764.CRC-22-0336

Ejemplares similares

Classification and challenges in the histopathological diagnosis of peripheral T-cell lymphomas, emphasis on the WHO-HAEM5 updates
por: Murga-Zamalloa, Carlos, et al.
Publicado: (2022)

JAK inhibitors for refractory lymphoma
por: Kimura, Hiroshi
Publicado: (2018)

Polo-like-kinase 1 (PLK-1) and c-myc inhibition with the dual kinase-bromodomain inhibitor volasertib in aggressive lymphomas
por: Murga-Zamalloa, Carlos, et al.
Publicado: (2017)

CD30 + Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report
por: Osmani, Kashif, et al.
Publicado: (2022)

Evaluating Acalabrutinib In The Treatment Of Mantle Cell Lymphoma: Design, Development, And Place In Therapy
por: Girard, Jennifer, et al.
Publicado: (2019)

MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma
por: Ramis-Zaldivar, Joan Enric, et al.
Publicado: (2021)

Contribution of JAK2 mutations to T-cell lymphoblastic lymphoma development
por: Roncero, A M, et al.
Publicado: (2016)

T-Cell Prolymphocytic Leukemia: Diagnosis, Pathogenesis, and Treatment
por: Gutierrez, Marc, et al.
Publicado: (2023)

CSF1R Protein Expression in Reactive Lymphoid Tissues and Lymphoma: Its Relevance in Classical Hodgkin Lymphoma
por: Martín-Moreno, Ana M., et al.
Publicado: (2015)

Recent Advances in the Management of Relapsed and Refractory Peripheral T-Cell Lymphomas
por: Braunstein, Zachary, et al.
Publicado: (2022)

ALK-driven tumors and targeted therapy: focus on crizotinib
por: Murga-Zamalloa, Carlos, et al.
Publicado: (2014)

The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
por: Derenzini, E, et al.
Publicado: (2011)

The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma
por: Derenzini, E, et al.
Publicado: (2014)

Tumor cell-free DNA detection in CSF for primary CNS lymphoma diagnosis
por: Rimelen, V., et al.
Publicado: (2019)

HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells
por: Schoof, Nils, et al.
Publicado: (2009)

Mutations in the JAK/STAT and RAS signaling pathways are common in Intestinal T-cell Lymphomas
por: Nicolae, Alina, et al.
Publicado: (2016)

JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL)
por: Vadivel, Chella Krishna, et al.
Publicado: (2021)

Targetable Metabolic Vulnerability in Diffuse Large B-Cell Lymphoma
por: Xiong, Jie, et al.
Publicado: (2018)

A phase II study of the oral JAK1/JAK2 inhibitor ruxolitinib in advanced relapsed/refractory Hodgkin lymphoma
por: Van Den Neste, Eric, et al.
Publicado: (2018)

Extranodal Natural Killer/T-Cell Lymphomas: Current Approaches and Future Directions
por: Reneau, John C., et al.
Publicado: (2022)

CSF TACI and BAFF levels in patients with primary CNS lymphoma as novel diagnostic biomarkers
por: Mizutani, Hironori, et al.
Publicado: (2018)

The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas
por: Tesfa, Daniel, et al.
Publicado: (2021)

Clonal expansion in follicular lymphoma occurs subsequent to antigenic selection
Publicado: (1992)

GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasms
por: Geng, Xiangrong, et al.
Publicado: (2022)

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
por: Ng, Samuel Y., et al.
Publicado: (2018)

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
por: Frontzek, Fabian, et al.
Publicado: (2021)

Lestaurtinib Inhibition of the JAK/STAT Signaling Pathway in Hodgkin Lymphoma Inhibits Proliferation and Induces Apoptosis
por: Diaz, Tania, et al.
Publicado: (2011)

New JAK3-INSL3 Fusion Transcript—An Oncogenic Event in Cutaneous T-Cell Lymphoma
por: Velatooru, Loka Reddy, et al.
Publicado: (2023)

Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma
por: Gebauer, Niklas, et al.
Publicado: (2021)

JAK inhibitors impair GM-CSF-mediated signaling in innate immune cells
por: Fujita, Yuya, et al.
Publicado: (2020)

An Atypical Presentation of Hemophagocytic Lymphohistiocytosis (HLH) Secondary to Occult Hodgkin Lymphoma
por: Komisarof, Justin, et al.
Publicado: (2021)

MCL-1 dependency as a novel vulnerability for aggressive B cell lymphomas
por: Wang, Michelle Y., et al.
Publicado: (2021)

Genetic alterations of JAK/STAT cascade and histone modification in extranodal NK/T-cell lymphoma nasal type
por: Lee, Seungbok, et al.
Publicado: (2015)

Aberrant JAK-STAT signaling-mediated chromatin remodeling impairs the sensitivity of NK/T-cell lymphoma to chidamide
por: Chen, Jinghong, et al.
Publicado: (2023)

Distinguishing reactive inflammatory dermatoses from lymphoma: 2 cases of severe drug reactions to phenytoin/phenobarbital and rosuvastatin mimicking lymphoma
por: Novice, Taylor, et al.
Publicado: (2020)

Progenitor expansion in apc mutants is mediated by Jak/Stat signaling
por: Lin, Junji, et al.
Publicado: (2011)

Interaction of ciliary disease protein retinitis pigmentosa GTPase regulator with nephronophthisis-associated proteins in mammalian retinas
por: Murga-Zamalloa, Carlos A., et al.
Publicado: (2010)

Gastrointestinal Myeloid Sarcoma a Case Presentation and Review of the Literature
por: Kheirkhah, Pouyan, et al.
Publicado: (2021)

Diverse in vivo effects of soluble and membrane-bound M-CSF on tumor-associated macrophages in lymphoma xenograft model
por: Liao, Jinfeng, et al.
Publicado: (2015)

Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy
por: Rapoport, AP, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_1mcvvvpeq3lbtgtb6nl34igotc